CSI Market
Sign In | Register

Odyssey Health Inc (ODYY) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ODYY Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Odyssey Health Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Apr 30 2026)
9 Months 		(Jan 31 2026) (Oct 31 2025) (Jul 31 2025) (Apr 30 2025)
Operating Activities
Income-3.32
Depreciation & amortization0.00
Amortization of Other Assets0.72
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation0.01
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-0.09
Increase Drcrease In Inprocess R D-
Financing Costs Paid With Stock-
Common Stock Issued For Debt Financing Commitment Shares-
Other Noninterest Expense-
Asset Purchase Liability-
Common Stock Issued For Debt Financing-
Financing Costs Paid Via Issuance Of Common Stock-
Financing Costs Paid With Issuance Of Common Stock-
Financing Costs3.08
Allowance For Research And Development Rebate Due-
Change In Fair Value Of Derivative Liability-
Income taxes0.00
Unrealized Gain (Loss) on Derivatives-1.50
Increase (Decrease) in Other Receivables0.00
Increase (Decrease) in Accounts Payable-0.05
Accrued Expense0.31
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-0.05
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities3.08
Discontinued operations0.00
Net Cash flow from Operating Activities-0.89
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Purchase Of Intellectual Property-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale of Investment Projects0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net1.17
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Financing Closing Costs Paid-
Financing Closing Costs Paid With Cash-
Interest Payments Made On Notes Payable-
Deferred Closing Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.17
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.89
Total Cash Flow0.28
4 historic quarters locked

Sign in to unlock the full Odyssey Health Inc cash flow history.

Sign In Create Free Account

About Odyssey Health Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001683168-26-004820

Figures are derived from filed reports and may be restated. Historical data is subject to revision.